Company: MYGN
Filing Date: 2025-06-05
Form Type: 8-K
Source: 0000899923-25-000066
Chunk: 1

Company: MYRIAD GENETICS INC
Filing Date: 2025-06-05
Form: 8-K
Item: Item 5.07
Chunk 1
---
ITEM 5.07 Submissions of Matters to a Vote of Security Holders

On June 5, 2025, Company held its Annual Meeting. Of the 92,171,423 shares of Company common stock outstanding as of the record date of April 8, 2025, a quorum of 82,230,185 shares, or approximately 89.21% of the outstanding shares of Company common stock, was present via webcast or represented by proxy.

The following is a brief description of each matter submitted to a vote at the Annual Meeting, as well as the number of votes cast for and against and the number of abstentions and broker non-votes with respect to each matter.

Proposal No. 1: Election of Directors

                                     Votes          Votes          Votes         Broker  
                                       For        Against      Abstained      Non-Votes  
 ─────────────────────────────────────────────────────────────────────────────────────────
  Samraat S. Raha               73,401,449        258,083         23,526      8,547,127  
  Heiner Dreismann, PH. D.      69,560,417      4,098,163         24,478      8,547,127  
  Colleen F. Reitan             69,922,952      3,732,650         27,456      8,547,127  

Each of Samraat S. Raha, Heiner Dreismann, PH. D., andColleen F. Reitan was elected to serve as a director of the Company for a term expiring at the 2028 Annual Meeting of Stockholders, and until his or her successor is duly elected and qualified or until his or her earlier death, resignation, retirement or removal.

Proposal No. 2: Ratification of the Selection of Ernst & Young LLP as Our Independent Registered Public Accounting Firm for the Fiscal Year Ending December 31, 2025

  Votes           Votes          Votes      
  For             Against        Abstained  
 ────────────────────────────────────────────
  78,614,062      3,591,463      24,660     

The ratification of the selection of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025, was approved by stockholders.

Proposal No. 3: Approval, on an Advisory Basis, of the Compensation of Our